Latest Category


Melphalan is an indispensable part of Multiple Myeloma treatment. Being available in oral dosage form, it adds to the convenience of the patient, especially in ‘all oral’ chemotherapy regimens.


A cell-cycle phase nonspecific alkylating antineoplastic agent. It is a nitrogen mustard β-chloro-nitrosourea compound. It is used in the treatment of brain tumors and various other malignant neoplasms, Multiple myeloma, Hodgkin’s and Non-Hodgkin’s lymphoma.


Leuprolide acetate is a gonadotropin-releasing hormone (GnRH) agonist. Leuprolide acetate is approved for palliative treatment of advanced Prostate cancer.


Bendamustine hydrochloride is a bifunctional chemotherapeutic agent with structurally similar to alkylating agents and purine analogues.


Busulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It has been used in the palliative treatment of Chronic Myeloid Leukemia (CML).


Fludarabine is a purine analogue that has replaced traditional alkylating agent based standard initial treatment of Chronic Lymphocytic Leukemia (CLL)